{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:09:01Z","timestamp":1773972541372,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["812915"],"award-info":[{"award-number":["812915"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117563","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T09:20:47Z","timestamp":1728811247000},"page":"117563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intradermal administration of novel particulate Chlamydia trachomatis vaccine candidates drives protective immune responses"],"prefix":"10.1016","volume":"180","author":[{"given":"Dung T.","family":"Huynh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Nolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia","family":"Guleed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Medfai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rienke F.","family":"Uijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-1611","authenticated-orcid":false,"given":"Peter","family":"van Ulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joen","family":"Luirink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice J.A.M.","family":"Sijts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter S.P.","family":"Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117563_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117563_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?","volume":"20","author":"de la Maza","year":"2021","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.biopha.2024.117563_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-023-00860-y","article-title":"Intracellular lifestyle of Chlamydia trachomatis and host\u2013pathogen interactions","author":"Stelzner","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2024.117563_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/mi.2007.19","article-title":"Chlamydia trachomatis infection: host immune responses and potential vaccines","volume":"1","author":"Hafner","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective chlamydial vaccine: Lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117563_bib7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14760584.2022.2117694","article-title":"Chlamydia trachomatis vaccine development\u2013a view on the current challenges and how to move forward","volume":"21","author":"Borges","year":"2022","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.biopha.2024.117563_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00197","article-title":"Genital infiltrations of CD4+and CD8+T lymphocytes, IgA+and IgG+plasma cells and intra-mucosal lymphoid follicles associate with protection against genital chlamydiatrachomatis infection in minipigs intramuscularly immunized with UV-inactivated bacteria a","volume":"10","author":"Erneholm","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.117563_bib10","first-page":"1","article-title":"Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model","volume":"13","author":"Coleman","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib11","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.1400120","article-title":"CD8 + T Cells Define an Unexpected Role in Live-Attenuated Vaccine Protective Immunity against Chlamydia trachomatis Infection in Macaques","volume":"192","author":"Olivares-Zavaleta","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: an update","volume":"323","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117563_bib13","series-title":"Current and new approaches for mucosal vaccine delivery","article-title":"Current and new approaches for mucosal vaccine delivery","author":"Rhee","year":"2019"},{"key":"10.1016\/j.biopha.2024.117563_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.biopha.2024.117563_bib15","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.5897\/AJB10.2681","article-title":"A novel and convenient method to immunize animals: Inclusion bodies from recombinant bacteria as antigen to directly immunize animals","volume":"10","author":"Yang","year":"2011","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117563_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020157","article-title":"The biological potential hidden in inclusion bodies","volume":"12","author":"Gifre-Renom","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117563_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tibs.2017.01.005","article-title":"Bacterial inclusion bodies: discovering their better half","volume":"42","author":"Rinas","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2024.117563_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41423-019-0298-x","article-title":"Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses","volume":"17","author":"Schetters","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib19","first-page":"1","article-title":"Toxicity pro fi ling of bacterial inclusion bodies in human caco-2 cells","volume":"10","author":"Barguilla","year":"2022"},{"key":"10.1016\/j.biopha.2024.117563_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vetpar.2007.03.023","article-title":"Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke","volume":"147","author":"Wedrychowicz","year":"2007","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2024.117563_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exppara.2015.11.002","article-title":"Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica","volume":"160","author":"Rivera","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2024.117563_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-017-0662-4","article-title":"Application of an E. coli signal sequence as a versatile inclusion body tag","volume":"16","author":"Jong","year":"2017","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.biopha.2024.117563_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2019.00442","article-title":"Mutagenesis-Based Characterization and Improvement of a Novel Inclusion Body Tag","volume":"7","author":"Jong","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117563_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/BST0350835","article-title":"The twin-arginine transport system: moving folded proteins across membranes","volume":"35","author":"Sargent","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2024.117563_bib25","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.vaccine.2021.10.006","article-title":"Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization","volume":"39","author":"van Beek","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.2011.346","article-title":"Intradermal immunization triggers epidermal langerhans cell mobilization required for CD8 T-cell immune responses","volume":"132","author":"Liard","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2024.117563_bib27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jid.2017.04.016","article-title":"Critical role for skin-derived migratory DCs and langerhans cells in TFH and GC responses after intradermal immunization","volume":"137","author":"Levin","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2024.117563_bib28","first-page":"88","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"95","author":"Villar","year":"2005","journal-title":"South Afr. Med. J."},{"key":"10.1016\/j.biopha.2024.117563_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","article-title":"Safety profile and immunologic responses of a novel vaccine against shigella sonnei administered intramuscularly, intradermally and intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe","volume":"22","author":"Launay","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2024.117563_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.molimm.2011.01.006","article-title":"Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development","volume":"48","author":"Kovjazin","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1381612811319060003","article-title":"HtrA protease family as therapeutic targets","volume":"19","author":"Skorko-Glonek","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2024.117563_bib32","doi-asserted-by":"crossref","unstructured":"J. Skorko-Glonek, D. Figaj, U. Zarzecka, T. Przepiora, J. Renke, B. Lipinska, The Extracellular Bacterial HtrA Proteins as Potential Therapeutic Targets and Vaccine Candidates, 2017. https:\/\/doi.org\/10.2174\/0929867323666161223145825.","DOI":"10.2174\/0929867323666161223145825"},{"key":"10.1016\/j.biopha.2024.117563_bib33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fmb-2017-0017","article-title":"CtHtrA: The lynchpin of the chlamydial surface and a promising therapeutic target","volume":"12","author":"Marsh","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.biopha.2024.117563_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.03101","article-title":"Chlamydia persistence: a survival strategy to evade antimicrobial effects in-vitro and in-vivo","volume":"9","author":"Panzetta","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.117563_bib35","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.febslet.2007.06.039","article-title":"The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 \u00b0C","volume":"581","author":"Huston","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2024.117563_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.f.367","article-title":"Endotoxin-free protein production\u2014ClearColi\u2122 technology","volume":"10","author":"Mamat","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2024.117563_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vaccine.2022.11.043","article-title":"Intradermal administration of the pneumococcal conjugate vaccine in mice results in lower antibody responses as compared to intramuscular administration","volume":"41","author":"Uijen","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib38","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.vaccine.2021.10.006","article-title":"Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization","volume":"39","author":"Van Beek","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.vaccine.2013.11.100","article-title":"Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model","volume":"32","author":"Olsen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib40","article-title":"Dataset-chemokines, cytokines, and biomarkers in the saliva of children with Sj\u00f6gren\u2019s syndrome","volume":"36","author":"Withanage","year":"2021","journal-title":"Data Br."},{"key":"10.1016\/j.biopha.2024.117563_bib41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117563_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ymthe.2017.01.010","article-title":"Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection","volume":"25","author":"Watkins","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2024.117563_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9080917","article-title":"The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development","volume":"9","author":"Yan","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2024.117563_bib44","first-page":"1","article-title":"But is not required in a vaccine strategy against genital infection with chlamydia trachomatis","volume":"12","author":"Dieu","year":"2021","journal-title":"Th1 \/ Th17 T Cell Tissue-Resid. Immun. Increases Prot."},{"key":"10.1016\/j.biopha.2024.117563_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00628","article-title":"Intramuscular priming and intranasal boosting induce strong genital immunity through secretory IgA in minipigs infected with Chlamydia trachomatis","volume":"6","author":"Lorenzen","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0897.2005.00267.x","article-title":"Immunologic uniqueness of the genital tract: challenge for vaccine development","volume":"53","author":"Mestecky","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"MacPherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-8-190","article-title":"Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA","volume":"8","author":"Huston","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.biopha.2024.117563_bib49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.vaccine.2013.08.020","article-title":"Development status and future prospects for a vaccine against Chlamydia trachomatis infection","volume":"32","author":"Hafner","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.117563_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","article-title":"An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial","volume":"24","author":"Pollock","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117563_bib51","first-page":"1","article-title":"Design of bacterial inclusion bodies as antigen carrier systems","volume":"2","author":"Chen","year":"2018","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.biopha.2024.117563_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(84)90550-6","article-title":"Human transforming growth factor-\u03b1: Precursor structure and expression in E. coli","volume":"38","author":"Derynck","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117563_bib53","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmeth1116","article-title":"Npro fusion technology to produce proteins with authentic N termini in E. coli","volume":"4","author":"Achm\u00fcller","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2024.117563_bib54","article-title":"Refinement of the Fusion Tag PagP for effective formation of inclusion bodies in escherichia coli","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2024.117563_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2021.734068","article-title":"Coiled-coil based inclusion bodies and their potential applications","volume":"9","author":"Gil-Garcia","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117563_bib56","first-page":"3433","article-title":"Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy","volume":"579","author":"Ami","year":"2005"},{"key":"10.1016\/j.biopha.2024.117563_bib57","first-page":"1","article-title":"Sublingual boosting with a novel mucoadhesive thermogelling hydrogel following parenteral CAF01 priming as a strategy against chlamydia trachomatis","volume":"2102508","author":"Garcia-del Rio","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2024.117563_bib58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2022.11.015","article-title":"Oral vaccination using microdevices to deliver \u03b1 -GalCer adjuvanted vaccine afford a mucosal immune response","volume":"353","author":"Carlsen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117563_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2330768","article-title":"Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses","volume":"20","author":"Huynh","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biopha.2024.117563_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.607945","article-title":"Modulation of immune responses by particle size and shape","volume":"11","author":"Baranov","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00569","article-title":"F. Follmann, Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted Chlamydia vaccine elicits elevated IgA and protective Th1\/Th17 responses in the genital tract","volume":"8","author":"Wern","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0162445","article-title":"Intravaginal Chlamydia trachomatis challenge infection elicits TH1 and TH17 immune responses in mice that promote pathogen clearance and genital tract damage","volume":"11","author":"Vicetti Miguel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117563_bib63","first-page":"1","article-title":"Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge","volume":"5","author":"Nguyen","year":"2020","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.biopha.2024.117563_bib64","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/eji.201545989","article-title":"CD8+ T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products","volume":"46","author":"Platteel","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jri.2009.07.013","article-title":"The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women","volume":"83","author":"Agrawal","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib66","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117563_bib67","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1128\/JVI.72.6.5137-5145.1998","article-title":"Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2","volume":"72","author":"Parr","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2024.117563_bib68","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","article-title":"Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles","volume":"95","author":"Nardelli-Haefliger","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2024.117563_bib69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","article-title":"T cells and the skin: from protective immunity to inflammatory skin disorders","volume":"19","author":"Ho","year":"2019","journal-title":"Nat. Rev. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:17:54Z","timestamp":1773969474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224014495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":69,"alternative-id":["S0753332224014495"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117563","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal administration of novel particulate Chlamydia trachomatis vaccine candidates drives protective immune responses","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117563"}}